Endpoint
Acute graft rejection incidence
CAT:outcome/acute-graft-rejection-incidencereported in risk ratio
How it is measured
Proportion of transplant recipients with at least one biopsy-proven or clinically treated acute rejection episode within the stated post-transplant window, usually twelve months. Whether episodes were biopsy-confirmed or treated empirically is recorded with each finding.